A carregar...
Discontinuation and dose adjustment of metoprolol after metoprolol‐paroxetine/fluoxetine co‐prescription in Dutch elderly
PURPOSE: Co‐prescription of paroxetine/fluoxetine (a strong CYP2D6 inhibitor) in metoprolol (a CYP2D6 substrate) users is common, but data on the clinical consequences of this drug‐drug interaction are limited and inconclusive. Therefore, we assessed the effect of paroxetine/fluoxetine initiation on...
Na minha lista:
| Publicado no: | Pharmacoepidemiol Drug Saf |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6001522/ https://ncbi.nlm.nih.gov/pubmed/29575226 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pds.4422 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|